Chris O’Brien MD PhD FCCP

Chris joined Kinaset in June 2022, bringing more than 20 years of experience in early and late phase clinical development across inhaled, oral, and biologic therapies. He has led over 25 Phase 2–4…

Is this you? Claim this profile →